Follow NCRAS on Twitter!
Join the NCRASmailing list!
Accessing cancer registration and other datasets.
2016 Cancer incidence and mortality numbers and rates published by ONS and PHE.
NCRAS is part of Public Health England (PHE), which exists to protect and improve the nation's health and wellbeing, as well as reduce health inequalities. PHE is an executive agency of the Department of Health, and a distinct delivery organisation with operational autonomy to advise and support government, local authorities and the NHS in a professionally independent manner.
The use MY data website has information on the benefits of using patient data.
The National Cancer Registration and Analysis Service
Updated Winter 2019
In 2016 the National Cancer Intelligence Network (NCIN) and National Disease Registration (NDR) merged to form the National Cancer Registration and Analysis Service (NCRAS). NCRAS works to drive improvements in standards of cancer care and clinical outcomes by improving and using the information collected about cancer patients for analysis, publication and research.
30 years of cancer intelligence - a look back on the history.
Find out more about NCRAS.
Achieving World Class Cancer Outcomes - A strategy for England - Executive summary and Report
Incidence, mortality, emergency presentations for 2016, comparisons made to 2015. Survival data for 2012-2016 followed up to 2017, compared to 2011-2015. Stage data (excl.'other' site) for 2017 compared to 2016.
Most recent publications
The following is a list of the most recent publications produced by NCRAS
NCRAS and ONS recently published survival statistics for cancer patients diagnosed between 2012 and 2016, followed up to 2017. The release includes a number of statistics on survival by stage.
A report examining cancer rates before during and after pregnancy helps add information to this little studied topic.
Updated stage breakdowns for 2012 to 2016 by CCG and cancer site are now available.
A large number of evaluation reports have been published examining the effectiveness of the Be Clear on Cancer campaigns - including looking at emergency presentations, Two Week Waits and diagnostic imaging amongst other measures.
Early results for Routes to Diagnosis have been updated to cover 2016, with the full publication up to 2015 being available with an accompanying interactive display. The project now covers over 10 years' worth of data, helping to contribute valuable information to the cancer landscape. Differences in cancer incidence by route comparing 2006 and 2015 can be seen below:
